Press release
Liquid Biopsy Market to Reach US$ 25.19 Billion by 2033, Driven by Rising Cancer Incidence and Precision Medicine Demand
According to DataM Intelligence, the Global Liquid Biopsy Market reached US$ 9.07 billion in 2024 and is projected to rise to US$ 25.19 billion by 2033, growing at a robust CAGR of 10.7% during 2025-2033. This growth is driven by increasing global cancer prevalence, advances in genomic research, and growing adoption of non-invasive diagnostic tools.Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/liquid-biospy-market?utm_source=OpenPR&utm_campaign=Onkar
Liquid biopsy-a minimally invasive test-detects biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and exosomes in body fluids. It offers key advantages for early cancer detection, monitoring therapy response, and tracking tumor progression. North America dominates the market due to strong healthcare infrastructure, FDA-backed innovation, and high investment in precision oncology.
Key Highlights from the Report
➤ Global liquid biopsy market to grow from US$ 9.07 billion in 2024 to US$ 25.19 billion by 2033 at a CAGR of 10.7%.
➤ Kits and reagents segment leads the market owing to continuous product launches and research demand.
➤ North America dominates the market with strong regulatory support and advanced precision medicine programs.
➤ Liquid biopsy applications expanding beyond oncology into prenatal testing and organ transplantation.
➤ Technological upgrades like Guardant Health's 739-gene panel enhance biomarker detection sensitivity.
➤ AI-driven platforms (e.g., SOPHiA GENETICS) enable real-time genomic analysis for personalized healthcare.
Market Segmentation
The global liquid biopsy market is segmented by product type, circulating biomarker, application, technology, end-user, and region.
Product Type: Kits and Reagents Lead Segment Growth
The kits and reagents segment holds the largest market share due to their integral role in extracting and analyzing biological samples such as ctDNA and cfDNA. Companies like Twist Bioscience and QIAGEN are expanding product lines to support clinical and research applications. QIAGEN's upgraded sample solutions (October 2024) and Twist Bioscience's cfDNA Library Prep Kit (February 2024) illustrate ongoing innovation fueling the sector's expansion.
Application: Oncology Dominates with Rising Use in Precision Cancer Diagnostics
Liquid biopsy tests are primarily used in oncology for cancer detection and therapeutic monitoring. They help clinicians assess tumor heterogeneity, track minimal residual disease, and optimize targeted drug selection. The expanding role of RNA-based testing, as seen in GeneCentric Therapeutics' EXpressCTSM platform, highlights diversification beyond classic DNA analysis.
Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/liquid-biospy-market?utm_source=OpenPR&utm_campaign=Onkar
Regional Insights
North America: Largest and Most Advanced Market
North America remains the dominant region due to widespread adoption of non-invasive diagnostics, a high cancer prevalence, and FDA support for biomarker-based testing. Guardant Health's 2024 launch of its enhanced Guardant360 test-analyzing 739 genes-demonstrates innovation leadership in detecting complex cancer mutations. Increasing precision oncology investments and research collaborations also support market growth.
Europe and Asia-Pacific: Emerging Hubs for Innovation
Europe benefits from growing demand for early diagnostic tools and expanding biomarker research collaborations. Meanwhile, Asia-Pacific is emerging as a strong growth region driven by rising cancer incidence, improving healthcare infrastructure, and regional collaborations promoting accessible genomic testing in countries like Japan, South Korea, and India.
Market Dynamics
Market Drivers
The continuous rise in global cancer cases fuels the need for early, precise, and non-invasive diagnostic approaches. Advances in genomics and biomarker studies allow for real-time monitoring of cancer dynamics, strengthening the clinical value of liquid biopsy in treatment planning and disease management.
Market Restraints
The lack of standardization in testing protocols remains a key restraint. Inconsistent sample processing methods, complex validation requirements, and high regulatory hurdles-particularly from the FDA and EMA-slow mass adoption and product approvals.
Market Opportunities
Integration of AI and machine learning in data interpretation, expanding applications in prenatal diagnostics, and commercialization of advanced biomarker test kits create lucrative opportunities. Strategic collaborations between biotechnology and diagnostic firms are set to accelerate adoption in both clinical and research segments.
Purchase This Exclusive Report at Just USD 4442 Only: https://www.datamintelligence.com/buy-now-page?report=liquid-biospy-market?utm_source=OpenPR&utm_campaign=Onkar
Reasons to Buy the Report
✔ In-depth market forecasts and growth insights through 2033.
✔ Comprehensive analysis of product innovations and technological advancements.
✔ Regional overview of market dynamics, investment patterns, and regulatory environment.
✔ Profiles of leading diagnostic and biotechnology companies driving innovation.
✔ Evaluation of AI integration and its impact on next-gen liquid biopsy platforms.
Frequently Asked Questions (FAQs)
◆ How big is the global liquid biopsy market in 2024?
◆ What is the projected market CAGR during 2025-2033?
◆ Which region dominates the global liquid biopsy market?
◆ Who are the key players revolutionizing the liquid biopsy landscape?
◆ What are the major growth factors influencing market expansion?
Company Insights
Exosome Sciences Inc.
Illumina, Inc.
Guardant Health, Inc.
Thermo Fisher Scientific Inc.
NeoGenomics Laboratories
QIAGEN
BioChain Institute Inc.
Sysmex Europe SE
Eurofins Genomics
Goffin Molecular Technologies
Recent Developments
February 2025: SOPHiA GENETICS achieved a major milestone, with 37 global institutions adopting its MSK-ACCESS and MSK-IMPACT AI-powered platforms, revolutionizing cancer testing and data-driven precision medicine.
October 2024: GeneCentric Therapeutics launched the EXpressCTSM liquid biopsy platform, expanding RNA-based diagnostic applications to include cfDNA in blood and urine assays.
Conclusion
The Global Liquid Biopsy Market is at the forefront of revolutionizing cancer diagnostics with its precision, speed, and non-invasive benefits. While North America continues to command leadership due to technological innovation, emerging markets across Asia-Pacific and Europe are accelerating adoption through research collaboration and improved genomic infrastructure. As regulatory clarity improves and AI-driven testing becomes mainstream, liquid biopsy is poised to become an essential tool for early cancer detection and personalized healthcare by 2033.
Contact Us
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com
About Us
DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liquid Biopsy Market to Reach US$ 25.19 Billion by 2033, Driven by Rising Cancer Incidence and Precision Medicine Demand here
News-ID: 4216248 • Views: …
More Releases from DataM Intelligence 4Market Research LLP
AI Data Centers Market to Surge to US$ 78.91 Billion by 2032, Fueled by Expandin …
According to DataM Intelligence, the Global AI Data Centers Market reached US$ 13.67 billion in 2024 and is projected to reach US$ 78.91 billion by 2032, expanding at a CAGR of 24.50% between 2025 and 2032. The market is witnessing exponential growth as artificial intelligence (AI) workloads drive demand for advanced computing infrastructure. AI data centers provide the backbone for applications like natural language processing (NLP), computer vision, and predictive…
Protein Supplements Market to Reach USD 12.1 Billion by 2030, Driven by Fitness …
According to DataM Intelligence, the Global Protein Supplements Market reached USD 6.5 billion in 2022 and is projected to achieve USD 12.1 billion by 2030, growing at a CAGR of 8.1% from 2024-2031. The market's robust growth is fueled by rising fitness awareness, demand for convenient nutritional intake, and product diversification across plant-based and protein-rich formulations.
Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a…
Supply Chain Cybersecurity Market to Reach US$ 2.24 Billion by 2033, Driven by Z …
According to DataM Intelligence, the Global Supply Chain Cybersecurity Market reached US$ 663.27 million in 2023, rose to US$ 706.40 million in 2024, and is projected to reach US$ 2,243.33 million by 2033, growing at a strong CAGR of 13.7% during the forecast period (2025-2033). The rise in cyberattacks targeting vendor networks and critical infrastructure has prompted global industries and governments to implement more stringent cybersecurity standards.
Get a Free Sample…
Carbon Farming Market to Soar to US$ 330.01 Billion by 2032, Driven by Climate G …
According to DataM Intelligence, the Global Carbon Farming Market reached US$ 113.36 million in 2024 and is projected to grow to US$ 330.01 billion by 2032, registering a robust CAGR of 14.29% during 2025-2032. Rising food demand, agricultural emissions accounting for around 11% of global greenhouse gases, and urgent climate mitigation needs are driving the adoption of carbon farming practices. By integrating sustainable techniques such as soil management, agroforestry, and…
More Releases for DNA
High-Quality Plasmid DNA Fuels Growth in Global DNA Plasmid Manufacturing Market
🌍 Market Overview
The DNA Plasmid Manufacturing Market is experiencing robust growth as advancements in cell & gene therapy, DNA vaccines, and genetic engineering continue to expand globally. Plasmid DNA plays a critical role as a raw material in the development of advanced therapies, fueling demand across biopharmaceutical research and production.
Key factors driving the market include:
Increasing adoption of gene and cell therapies
Rising prevalence of chronic and rare genetic disorders
Expansion of DNA-based…
DNA Synthesis Market Increasing Demand for Synthetic Genes and DNA Sequences
As demonstrated by Precision Business Insights (PBI), the latest report, the global DNA synthesis market was valued at USD 3,702.0 million in 2023 and is expected to reach USD 10,289.5 million by 2029, growing at a CAGR of 18.6% during the forecast period 2024-2030. The key drivers for the growth of the global DNA synthesis market include increasing demand for synthetic genes and DNA sequences, growing applications in the agriculture…
Wealth DNA Code Review Legit Price? (Wealth Manifestation DNA Code Audio Frequen …
Wealth DNA Code Wealth DNA Code is a digital program with seven minutes of soundtracks that manifest and listen to daily to activate the "Wealth DNA," which is part of your DNA to help you attract wealth by making money a part of your mentality and making your dreams to come true.
https://bit.ly/Visit-The-Official-Website-Here-To-Order-Wealth-DNA-Code
Making money, creating assets as well as increasing wealth are the primary objectives that every human being has to…
DNA Paternity Testing Market Size [2022-2029] -DNA Diagnostics Center, EasyDNA, …
A recent market research report added to repository of MR Accuracy Reports is an in-depth analysis of global DNA Paternity Testing. On the basis of historic growth analysis and current scenario of DNA Paternity Testing place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent…
DNA Paternity Testing Market Trends 2020 | Growth by Top Companies: DNA Diagnost …
The report begins with the overview of the DNA Paternity Testing Market and offers throughout development. It presents a comprehensive analysis of all the regional and major player segments that gives closer insights upon present market conditions and future market opportunities along with drivers, trending segments, consumer behaviour, pricing factors and market performance and estimation. The forecast market information, SWOT analysis, DNA Paternity Testing market scenario, and feasibility study are…
DNA Paternity Testing Market Rapidly Growing in Healthcare, Competitor Analysis …
The exclusive research report on the Global DNA Paternity Testing Market 2020 examines the market in detail along with focusing on significant market dynamics for the key players operating in the market. Global DNA Paternity Testing Industry research report offers granulated yet in-depth analysis of revenue share, market segments, revenue estimates and various regions across the globe.
Overview of Global DNA Paternity Testing Market:
This report studies the Global DNA Paternity Testing…
